Product
MK-4334
1 clinical trial
1 indication
Indication
Neurocognitive ImpairmentClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Cross-over Evaluation of Evoked Responses as Pharmacodynamic Biomarkers in Healthy Adults and Schizophrenic PatientsStatus: Completed, Estimated PCD: 2022-09-23